📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

PARMAXPharmaceuticals

Parmax Pharma Ltd — Financial Ratios & Key Metrics

₹28.44

-9.12%

P/E RatioN/AxIndustry: 31.77x

ROEN/AReturn on equity

ROCE-12.45%Return on capital

Debt/EquityN/ADebt free ✓

💎

Valuation & Profitability

P/E Ratio

N/Ax

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹12.83 (Cr)

Sales Growth 5Y

6.15%

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

5.19%

📉

Price Returns

1 Month

-0.23%

3 Months

-2.89%

6 Months

-17.77%

1 Year

-31.08%

52W Low

₹23

Current

₹28

52W High

₹55

18% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹32

▼ Price below SMA 50 — Bearish

SMA 200

₹34

▼ Long-term downtrend

Volume Signal

91% of avg

Average volume

Technical indicators are for educational purposes only. Not investment advice.

More on Parmax Pharma Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.